{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:13Z","timestamp":1772136493426,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["13XP5029A"],"award-info":[{"award-number":["13XP5029A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["PLU-2017-056\/2-1"],"award-info":[{"award-number":["PLU-2017-056\/2-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Uncovering the complex cellular mechanisms underlying hepatic fibrogenesis could expedite the development of effective treatments and noninvasive diagnosis for liver fibrosis. The biochemical complexity of extracellular vesicles (EVs) and their role in intercellular communication make them an attractive tool to look for biomarkers as potential alternative to liver biopsies. We developed a solid set of methods to isolate and characterize EVs from differently treated human hepatic stellate cell (HSC) line LX-2, and we investigated their biological effect onto na\u00efve LX-2, proving that EVs do play an active role in fibrogenesis. We mined our proteomic data for EV-associated proteins whose expression correlated with HSC treatment, choosing the matricellular protein SPARC as proof-of-concept for the feasibility of fluorescence nanoparticle-tracking analysis to determine an EV-based HSCs\u2019 fibrogenic phenotype. We thus used EVs to directly evaluate the efficacy of treatment with S80, a polyenylphosphatidylcholines-rich lipid, finding that S80 reduces the relative presence of SPARC-positive EVs. Here we correlated the cellular response to lipid-based antifibrotic treatment to the relative presence of a candidate protein marker associated with the released EVs. Along with providing insights into polyenylphosphatidylcholines treatments, our findings pave the way for precise and less invasive diagnostic analyses of hepatic fibrogenesis.<\/jats:p>","DOI":"10.1038\/s42003-022-04123-z","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T05:02:46Z","timestamp":1667106166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4933-156X","authenticated-orcid":false,"given":"Cristina","family":"Zivko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-5126","authenticated-orcid":false,"given":"Gregor","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-0149","authenticated-orcid":false,"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"4123_CR1","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts, E., Gannon, M. & Wasserman, D. H. The liver. Curr. Biol. 27, R1147\u2013R1151 (2017).","journal-title":"Curr. Biol."},{"key":"4123_CR2","doi-asserted-by":"publisher","first-page":"129559","DOI":"10.1016\/j.bbagen.2020.129559","volume":"1865","author":"C Zivko","year":"2020","unstructured":"Zivko, C., Fuhrmann, G. & Luciani, P. Liver-derived extracellular vesicles: a cell by cell overview to isolation and characterization practices. Biochim. Biophys. Acta Gen. Subj. 1865, 129559 (2020).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"4123_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"4123_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0159-5","volume":"12","author":"P Byass","year":"2014","unstructured":"Byass, P. The global burden of liver disease: a challenge for methods and for public health. BMC Med. 12, 159 (2014).","journal-title":"BMC Med."},{"key":"4123_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin, L. et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 69, 718\u2013735 (2018).","journal-title":"J. Hepatol."},{"key":"4123_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/liv.13682","volume":"38","author":"P Marcellin","year":"2018","unstructured":"Marcellin, P. & Kutala, B. K. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 38, 2\u20136 (2018).","journal-title":"Liver Int"},{"key":"4123_CR7","doi-asserted-by":"publisher","first-page":"e013620","DOI":"10.1136\/bmjopen-2016-013620","volume":"7","author":"N Ndugga","year":"2017","unstructured":"Ndugga, N. et al. Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA. BMJ Open 7, e013620 (2017).","journal-title":"BMJ Open"},{"key":"4123_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4123_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"CR Gandhi","year":"2017","unstructured":"Gandhi, C. R. Hepatic stellate cell activation and pro-fibrogenic signals. J. Hepatol. 67, 1104\u20131105 (2017).","journal-title":"J. Hepatol."},{"key":"4123_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-2001-17558","volume":"21","author":"R Bataller","year":"2001","unstructured":"Bataller, R. & Brenner, D. A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21, 437\u2013451 (2001).","journal-title":"Semin. Liver Dis."},{"key":"4123_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola, M. & Pinzani, M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol. Asp. Med. 65, 37\u201355 (2019).","journal-title":"Mol. Asp. Med."},{"key":"4123_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/ijms20071745","volume":"20","author":"A Sircana","year":"2019","unstructured":"Sircana, A., Paschetta, E., Saba, F., Molinaro, F. & Musso, G. Recent insight into the role of fibrosis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. Int. J. Mol. Sci. 20, 1745 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.20517\/2394-5079.2017.27","volume":"3","author":"JY-K Cheng","year":"2017","unstructured":"Cheng, J. Y.-K. & Wong, G. L.-H. Advances in the diagnosis and treatment of liver fibrosis. Hepatoma Res. 3, 156 (2017).","journal-title":"Hepatoma Res."},{"key":"4123_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh, S. et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin. Gastroenterol. Hepatol. 13, 440\u2013451.e6 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"4123_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/apt.13524","volume":"43","author":"CS Pavlov","year":"2016","unstructured":"Pavlov, C. S. et al. Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease. Aliment. Pharmacol. Ther. 43, 575\u2013585 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"4123_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","volume":"71","author":"J Boursier","year":"2019","unstructured":"Boursier, J. et al. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J. Hepatol. 71, 389\u2013396 (2019).","journal-title":"J. Hepatol."},{"key":"4123_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","volume":"134","author":"M Friedrich-Rust","year":"2008","unstructured":"Friedrich-Rust, M. et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134, 960\u2013974 (2008).","journal-title":"Gastroenterology"},{"key":"4123_CR18","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655\u20131669 (2008).","journal-title":"Gastroenterology"},{"key":"4123_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: Immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181\u2013194 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"4123_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nantod.2015.04.004","volume":"10","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann, G., Herrmann, I. K. & Stevens, M. M. Cell-derived vesicles for drug therapy and diagnostics: Opportunities and challenges. Nano Today 10, 397\u2013409 (2015).","journal-title":"Nano Today"},{"key":"4123_CR21","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3390\/ijms20092180","volume":"20","author":"K Sato","year":"2019","unstructured":"Sato, K. et al. Intercellular communication between hepatic cells in liver diseases. Int. J. Mol. Sci. 20, 2180 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"4123_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4123_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol, E., B\u00f6ing, A. N., Harrison, P., Sturk, A. & Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64, 676\u2013705 (2012).","journal-title":"Pharmacol. Rev."},{"key":"4123_CR24","doi-asserted-by":"publisher","first-page":"29497","DOI":"10.3402\/jev.v5.29497","volume":"5","author":"F Royo","year":"2016","unstructured":"Royo, F. et al. Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples. J. Extracell. Vesicles 5, 29497 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12471-013-0462-3","volume":"21","author":"JW Wang","year":"2013","unstructured":"Wang, J. W. et al. Plasma extra cellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. Neth. Hear. J. 21, 467\u2013471 (2013).","journal-title":"Neth. Hear. J."},{"key":"4123_CR26","doi-asserted-by":"publisher","first-page":"070","DOI":"10.1055\/s-0038-1676122","volume":"39","author":"S Urban","year":"2019","unstructured":"Urban, S., Mocan, T., S\u00e4nger, H., Lukacs-Kornek, V. & Kornek, M. Extracellular vesicles in liver diseases: diagnostic, prognostic, and therapeutic application. Semin. Liver Dis. 39, 070\u2013077 (2019).","journal-title":"Semin. Liver Dis."},{"key":"4123_CR27","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu, L. et al. Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut 54, 142\u2013151 (2005).","journal-title":"Gut"},{"key":"4123_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/pharmaceutics11120676","volume":"11","author":"G Valentino","year":"2019","unstructured":"Valentino, G., Zivko, C., Weber, F., Br\u00fclisauer, L. & Luciani, P. Synergy of phospholipid\u2014Drug formulations significantly deactivates profibrogenic human hepatic stellate cells. Pharmaceutics 11, 676 (2019).","journal-title":"Pharmaceutics"},{"key":"4123_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI12939","volume":"107","author":"AD Bradshaw","year":"2001","unstructured":"Bradshaw, A. D. & Sage, E. H. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107, 1049\u20131054 (2001).","journal-title":"J. Clin. Invest."},{"key":"4123_CR31","doi-asserted-by":"publisher","first-page":"36483","DOI":"10.1074\/jbc.M504663200","volume":"280","author":"TH Barker","year":"2005","unstructured":"Barker, T. H. et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J. Biol. Chem. 280, 36483\u201336493 (2005).","journal-title":"J. Biol. Chem."},{"key":"4123_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/gt.2014.102","volume":"22","author":"E Peixoto","year":"2015","unstructured":"Peixoto, E. et al. SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage. Gene Ther. 22, 9\u201319 (2015).","journal-title":"Gene Ther."},{"key":"4123_CR33","first-page":"105","volume":"9","author":"KJ Gundermann","year":"2016","unstructured":"Gundermann, K. J., Gundermann, S., Drozdzik, M. & Mohan Prasad, V. G. Essential phospholipids in fatty liver: a scientific update. Clin. Exp. Gastroenterol. 9, 105\u2013117 (2016).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"4123_CR34","doi-asserted-by":"crossref","unstructured":"Varganova, D. L., Pavlov, C. S., Casazza, G., Nikolova, D. & Gluud, C. Essential phospholipids for people with non-alcoholic fatty liver disease (Protocol). Cochrane Database Syst. Rev. 2019 (2019).","DOI":"10.1002\/14651858.CD013301"},{"key":"4123_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajg.2015.09.001","volume":"16","author":"AIM Dajani","year":"2015","unstructured":"Dajani, A. I. M. et al. Essential phospholipids as a supportive adjunct in the management of patients with NAFLD. Arab J. Gastroenterol. 16, 99\u2013104 (2015).","journal-title":"Arab J. Gastroenterol."},{"key":"4123_CR36","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.1021\/acs.analchem.5b01636","volume":"87","author":"S Sitar","year":"2015","unstructured":"Sitar, S. et al. Size characterization and quantification of exosomes by asymmetrical-flow field-flow fractionation. Anal. Chem. 87, 9225\u20139233 (2015).","journal-title":"Anal. Chem."},{"key":"4123_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41596-019-0126-x","volume":"14","author":"H Zhang","year":"2019","unstructured":"Zhang, H. & Lyden, D. Asymmetric-flow field-flow fractionation technology for exomere and small extracellular vesicle separation and characterization. Nat. Protoc. 14, 1027\u20131053 (2019).","journal-title":"Nat. Protoc."},{"key":"4123_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.aca.2020.06.071","volume":"1127","author":"B Wu","year":"2020","unstructured":"Wu, B. et al. Separation and characterization of extracellular vesicles from human plasma by asymmetrical flow field-flow fractionation. Anal. Chim. Acta 1127, 234\u2013245 (2020).","journal-title":"Anal. Chim. Acta"},{"key":"4123_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332\u2013343 (2018).","journal-title":"Nat. Cell Biol."},{"key":"4123_CR40","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/acssensors.9b00418","volume":"4","author":"S Cavallaro","year":"2019","unstructured":"Cavallaro, S. et al. Label-free surface protein profiling of extracellular vesicles by an electrokinetic sensor. ACS Sens. 4, 1399\u20131408 (2019).","journal-title":"ACS Sens."},{"key":"4123_CR41","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1021\/ac504712n","volume":"87","author":"C Johann","year":"2015","unstructured":"Johann, C., Elsenberg, S., Schuch, H. & R\u00f6sch, U. Instrument and method to determine the electrophoretic mobility of nanoparticles and proteins by combining electrical and flow field-flow fractionation. Anal. Chem. 87, 4292\u20134298 (2015).","journal-title":"Anal. Chem."},{"key":"4123_CR42","doi-asserted-by":"publisher","first-page":"461625","DOI":"10.1016\/j.chroma.2020.461625","volume":"1633","author":"J Choi","year":"2020","unstructured":"Choi, J., Fuentes, C., Fransson, J., Wahlgren, M. & Nilsson, L. Separation and zeta-potential determination of proteins and their oligomers using electrical asymmetrical flow field-flow fractionation (EAF4). J. Chromatogr. A 1633, 461625 (2020).","journal-title":"J. Chromatogr. A"},{"key":"4123_CR43","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","volume":"29","author":"R Dobie","year":"2019","unstructured":"Dobie, R. et al. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep. 29, 1832\u20131847.e8 (2019).","journal-title":"Cell Rep."},{"key":"4123_CR44","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.772403","volume":"13","author":"PD Thomas","year":"2003","unstructured":"Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13, 2129\u20132141 (2003).","journal-title":"Genome Res."},{"key":"4123_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","volume":"14","author":"H Mi","year":"2019","unstructured":"Mi, H. et al. Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat. Protoc. 14, 703\u2013721 (2019).","journal-title":"Nat. Protoc."},{"key":"4123_CR46","doi-asserted-by":"publisher","first-page":"D204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"A Bateman","year":"2015","unstructured":"Bateman, A. et al. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204\u2013D212 (2015).","journal-title":"Nucleic Acids Res."},{"key":"4123_CR47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1074\/mcp.M116.064725","volume":"16","author":"P Larssen","year":"2017","unstructured":"Larssen, P. et al. Tracing cellular origin of human exosomes using multiplex proximity extension assays. Mol. Cell. Proteom. 16, 502\u2013511 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"4123_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejpb.2004.03.034","volume":"58","author":"W Fraunhofer","year":"2004","unstructured":"Fraunhofer, W. & Winter, G. The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur. J. Pharm. Biopharm. 58, 369\u2013383 (2004).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"4123_CR49","doi-asserted-by":"crossref","unstructured":"Bria, C. R. M. & Williams, S. K. R. Impact of asymmetrical flow field-flow fractionation on protein aggregates stability. J. Chromatogr. A 1465, 155\u2013164 (2016).","DOI":"10.1016\/j.chroma.2016.08.037"},{"key":"4123_CR50","first-page":"155","volume":"1465","author":"A Citkowicz","year":"2008","unstructured":"Citkowicz, A. et al. Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering. Anal. Biochem. 1465, 155\u2013164 (2008).","journal-title":"Anal. Biochem."},{"key":"4123_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30786-y","volume":"8","author":"J Frank","year":"2018","unstructured":"Frank, J. et al. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying. Sci. Rep. 8, 12377 (2018).","journal-title":"Sci. Rep."},{"key":"4123_CR52","doi-asserted-by":"publisher","first-page":"31803","DOI":"10.3402\/jev.v5.31803","volume":"5","author":"M Oliveira-Rodr\u00edguez","year":"2016","unstructured":"Oliveira-Rodr\u00edguez, M. et al. Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids. J. Extracell. Vesicles 5, 31803 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR53","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","volume":"315","author":"MS Pols","year":"2009","unstructured":"Pols, M. S. & Klumperman, J. Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 315, 1584\u20131592 (2009).","journal-title":"Exp. Cell Res."},{"key":"4123_CR54","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1074\/jbc.M112.445304","volume":"288","author":"D Perez-Hernandez","year":"2013","unstructured":"Perez-Hernandez, D. et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 288, 11649\u201311661 (2013).","journal-title":"J. Biol. Chem."},{"key":"4123_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tcb.2013.10.009","volume":"24","author":"C Bissig","year":"2014","unstructured":"Bissig, C. & Gruenberg, J. ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol. 24, 19\u201325 (2014).","journal-title":"Trends Cell Biol."},{"key":"4123_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48181-6","volume":"9","author":"KE Thane","year":"2019","unstructured":"Thane, K. E., Davis, A. M. & Hoffman, A. M. Improved methods for fluorescent labeling and detection of single extracellular vesicles using nanoparticle tracking analysis. Sci. Rep. 9, 1\u201313 (2019).","journal-title":"Sci. Rep."},{"key":"4123_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0623-9","volume":"13","author":"F Momen-Heravi","year":"2015","unstructured":"Momen-Heravi, F. et al. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J. Transl. Med. 13, 261 (2015).","journal-title":"J. Transl. Med."},{"key":"4123_CR58","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino, A. et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell 182, 1044\u20131061.e18 (2020).","journal-title":"Cell"},{"key":"4123_CR59","doi-asserted-by":"publisher","first-page":"1713526","DOI":"10.1080\/20013078.2020.1713526","volume":"9","author":"JA Welsh","year":"2020","unstructured":"Welsh, J. A. et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J. Extracell. Vesicles 9, 1713526 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR60","doi-asserted-by":"publisher","first-page":"32945","DOI":"10.3402\/jev.v5.32945","volume":"5","author":"C Gardiner","year":"2016","unstructured":"Gardiner, C. et al. Techniques used for the isolation and characterization of extracellular vesicles: Results of a worldwide survey. J. Extracell. Vesicles 5, 32945 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR61","doi-asserted-by":"publisher","first-page":"e97945","DOI":"10.1371\/journal.pone.0097945","volume":"9","author":"CM Freeman","year":"2014","unstructured":"Freeman, C. M. et al. Characterization of microparticles after hepatic ischemia-reperfusion injury. PLoS ONE 9, e97945 (2014).","journal-title":"PLoS ONE"},{"key":"4123_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejpb.2019.11.010","volume":"146","author":"E Schulz","year":"2020","unstructured":"Schulz, E., Karagianni, A., Koch, M. & Fuhrmann, G. Hot EVs - How temperature affects extracellular vesicles. Eur. J. Pharm. Biopharm. 146, 55\u201363 (2020).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"4123_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fimmu.2015.00050","volume":"6","author":"M S\u00e1enz-Cuesta","year":"2015","unstructured":"S\u00e1enz-Cuesta, M. et al. Methods for extracellular vesicles isolation in a hospital setting. Front. Immunol. 6, 50 (2015).","journal-title":"Front. Immunol."},{"key":"4123_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","volume":"7","author":"RA Dragovic","year":"2011","unstructured":"Dragovic, R. A. et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 7, 780\u2013788 (2011).","journal-title":"Nanomedicine"},{"key":"4123_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ymeth.2015.03.028","volume":"87","author":"RA Dragovic","year":"2015","unstructured":"Dragovic, R. A. et al. Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence nanoparticle tracking analysis. Methods 87, 64\u201374 (2015).","journal-title":"Methods"},{"key":"4123_CR66","doi-asserted-by":"publisher","first-page":"e54962","DOI":"10.1371\/journal.pone.0054962","volume":"8","author":"C Atorrasagasti","year":"2013","unstructured":"Atorrasagasti, C. et al. Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice. PLoS ONE 8, e54962 (2013).","journal-title":"PLoS ONE"},{"key":"4123_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1874312901206010146","volume":"6","author":"J Trombetta-eSilva","year":"2012","unstructured":"Trombetta-eSilva, J. The function of SPARC as a mediator of fibrosis. Open Rheumatol. J. 6, 146\u2013155 (2012).","journal-title":"Open Rheumatol. J."},{"key":"4123_CR68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/jgm.1228","volume":"10","author":"AM Camino","year":"2008","unstructured":"Camino, A. M. et al. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J. Gene Med. 10, 993\u20131004 (2008).","journal-title":"J. Gene Med."},{"key":"4123_CR69","doi-asserted-by":"publisher","first-page":"118940","DOI":"10.1016\/j.ijpharm.2019.118940","volume":"574","author":"J Wang","year":"2020","unstructured":"Wang, J., Ding, Y. & Zhou, W. Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways. Int. J. Pharm. 574, 118940 (2020).","journal-title":"Int. J. Pharm."},{"key":"4123_CR70","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/liv.14857","volume":"41","author":"A Onorato","year":"2021","unstructured":"Onorato, A. et al. SPARC inhibition accelerates NAFLD\u2010associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism. Liver Int. 41, 1677\u20131693 (2021).","journal-title":"Liver Int."},{"key":"4123_CR71","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ejca.2013.12.019","volume":"50","author":"A Riches","year":"2014","unstructured":"Riches, A., Campbell, E., Borger, E. & Powis, S. Regulation of exosome release from mammary epithelial and breast cancer cells-A new regulatory pathway. Eur. J. Cancer 50, 1025\u20131034 (2014).","journal-title":"Eur. J. Cancer"},{"key":"4123_CR72","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1089\/scd.2014.0316","volume":"24","author":"A Shabbir","year":"2015","unstructured":"Shabbir, A., Cox, A., Rodriguez-Menocal, L., Salgado, M. & Van Badiavas, E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 24, 1635\u20131647 (2015).","journal-title":"Stem Cells Dev."},{"key":"4123_CR73","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/blood-2004-03-0824","volume":"104","author":"AE Morelli","year":"2004","unstructured":"Morelli, A. E. et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104, 3257\u20133266 (2004).","journal-title":"Blood"},{"key":"4123_CR74","doi-asserted-by":"publisher","first-page":"1388731","DOI":"10.1080\/20013078.2017.1388731","volume":"6","author":"K Takov","year":"2017","unstructured":"Takov, K., Yellon, D. M. & Davidson, S. M. Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes. J. Extracell. Vesicles 6, 1388731 (2017).","journal-title":"J. Extracell. Vesicles"},{"key":"4123_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-66434-7","volume":"10","author":"M Dehghani","year":"2020","unstructured":"Dehghani, M., Gulvin, S. M., Flax, J. & Gaborski, T. R. Systematic evaluation of PKH labelling on extracellular vesicle size by nanoparticle tracking analysis. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"4123_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fphar.2018.00169","volume":"9","author":"P Gangadaran","year":"2018","unstructured":"Gangadaran, P., Hong, C. M. & Ahn, B. C. An update on in vivo imaging of extracellular vesicles as drug delivery vehicles. Front. Pharmacol. 9, 169 (2018).","journal-title":"Front. Pharmacol."},{"key":"4123_CR77","doi-asserted-by":"crossref","unstructured":"Richter, M., Fuhrmann, K. & Fuhrmann, G. Evaluation of the storage stability of extracellular vesicles. J. Vis. Exp. e59584 (2019).","DOI":"10.3791\/59584"},{"key":"4123_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2018.02.023","volume":"168","author":"L Rahnfeld","year":"2018","unstructured":"Rahnfeld, L., Thamm, J., Steiniger, F., van Hoogevest, P. & Luciani, P. Study on the in situ aggregation of liposomes with negatively charged phospholipids for use as injectable depot formulation. Colloids Surf. B Biointerfaces 168, 10\u201317 (2018).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"4123_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ymeth.2015.04.014","volume":"87","author":"TA Lydic","year":"2015","unstructured":"Lydic, T. A. et al. Rapid and comprehensive \u2018shotgun\u2019 lipidome profiling of colorectal cancer cell derived exosomes. Methods 87, 83\u201395 (2015).","journal-title":"Methods"},{"key":"4123_CR80","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1074\/mcp.M600326-MCP200","volume":"6","author":"M Heller","year":"2007","unstructured":"Heller, M., Schlappritzi, E., Stalder, D., Nuoffer, J. M. & Haeberli, A. Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS\/MS and probabilistic peptide scoring. Mol. Cell. Proteom. 6, 1059\u20131072 (2007).","journal-title":"Mol. Cell. Proteom."},{"key":"4123_CR81","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1074\/mcp.M116.060491","volume":"15","author":"S Braga-Lagache","year":"2016","unstructured":"Braga-Lagache, S. et al. Robust label-free, quantitative profiling of circulating plasma microparticle (MP) associated proteins. Mol. Cell. Proteom. 15, 3640\u20133652 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"4123_CR82","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"4123_CR83","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794\u20131805 (2011).","journal-title":"J. Proteome Res."},{"key":"4123_CR84","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a Hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"4123_CR85","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3389\/fimmu.2019.01634","volume":"10","author":"J Hoppst\u00e4dter","year":"2019","unstructured":"Hoppst\u00e4dter, J. et al. Toll-like receptor 2 release by macrophages: an anti-inflammatory program induced by glucocorticoids and lipopolysaccharide. Front. Immunol. 10, 1634 (2019).","journal-title":"Front. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04123-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T08:05:53Z","timestamp":1667117153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04123-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04123-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1124359\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No private study sponsors had any involvement in the study design, data collection, or interpretation of data presented in this manuscript. P.L. declares the following competing interests: she has consulted Lipoid GmbH and Sanofi-Aventis Deutschland and received research grants from Lipoid, Sanofi-Aventis Deutschland and DSM Nutritional Products Ltd. C.Z., K.F., and G.F. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1155"}}